Patent · US Active

Vector for targeting the human Rosa26 gene

US11078494B2 · kind B2 · utility

0Cited by

4References

11Claims

0Family size

Assignee

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · US

Inventors

Gordon Keller · Denver, US
Stefan Irion · Toronto, CA
Herve Luche · Ulm, DE
Paul Gadue · New York, US
Hans J. Fehling · Ulm, DE

Key dates

Filing date	Oct 25, 2019
Grant date	Aug 3, 2021
Priority date	—
Expiry date	Oct 25, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2840/44
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides a method for generating a transgenic eukaryotic cell population having a modified human Rosa26 locus, which method includes introducing a functional DNA sequence into the human Rosa26 locus of starting eukaryotic cells. Also provided are targeting vectors useful in the method, as well as a cell population and a transgenic non-human animal comprising a modified human Rosa26 locus. Finally, the invention provides an isolated DNA sequence corresponding to the human Rosa26 locus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.